Pressmeddelande -
Delphi advisor to AddLife in the acquisition of Biomedica
Delphi has assisted AddLife AB in the acquisition of Austrian Biomedica Medizinprodukte GmbH (“Biomedica”). Biomedica is the parent company of a group that operates in 13 countries across Europe and has approximately 280 employees. Biomedica supplies, like AddLife, products and services in laboratory engineering and medical technology to mainly publicly funded healthcare. Through the acquisition of Biomedica, AddLife establishes a strong base in Europe and extends its geographic market from a population of about 32 million people to about 164 million people.
Delphi has been lead counsel in the acquisition and cooperated with the law firm Schönherr in Austria.
Delphi’s team consisted of Mats Dahlberg as responsible partner, Glenn Nyström, Matilda Karlsson, Emil Blomqvist, Christoffer Malmström, Johanna Liljegren and Fredrik Nykvist.
Ämnen
Kategorier
Regioner
Delphi is one of the top commercial law firms in Sweden. We help our clients with mergers and acquisitions. We advise them on matters of banking, finance and capital markets. We represent clients in court and in arbitration and are acknowledged as being extremely competent in public procurement, environmental law and real estate law.
Many of us are specialists in high-tech fields such as IT, intellectual property and life science. Our drive and our interest in technology and business probably explain, in part, our success. We are often praised for our commercial sense and our ability to understand the client’s business.
Our clients are to be found primarily in Scandinavia, Europe and North America. We also co-operate with law firms globally and regularly assist clients on international matters. We have a total workforce of approximately 185, of which more than 120 are lawyers. We have offices in Stockholm, Göteborg, Malmö, Linköping and Norrköping.
